Met Life Investment Management, LLC Collegium Pharmaceutical, Inc Transaction History
Met Life Investment Management, LLC
- $16.6 Billion
- Q2 2024
A detailed history of Met Life Investment Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 18,429 shares of COLL stock, worth $705,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,429
Previous 16,582
11.14%
Holding current value
$705,093
Previous $643,000
7.78%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding COLL
# of Institutions
236Shares Held
39.4MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$222 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$130 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$101 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$90.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$89.3 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.31B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...